This Week in Virology

TWiV is a weekly netcast about viruses - the kind that make you sick. Brought to you by four university professors and a science writer.

http://www.microbe.tv/twiv

subscribe
share






episode 845: COVID-19 clinical update #94 with Dr. Daniel Griffin


In COVID-19 clinical update #94, Daniel Griffin reviews the FDA EUA for Paxlovid, test to stay in school, immunity after infection, variants and therapeutics, quarantine and isolation guidelines, Molnupiravir in non-hospitalized patients, and convalescent serum in outpatients.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode
  • FDA EUA for Paxlovid (pdf)
  • Children and COVID-19 (pdf)
  • Evaluation of test to stay in school, IL (MMWR)
  • Evaluation of test to stay in school, LA (MMWR)
  • Update on mRNA vaccine in under 5 yo (Pfizer)
  • CDC endorses preference for mRNA vaccines (CDC)
  • Natural immunity and protection against delta (Clin Inf Dis)
  • Cross-neutralization post-vaccination infection (JAMA)
  • Variants and therapeutics (NIH)
  • Quarantine and isolation (CDC)
  • Molnupiravir in non-hospitalized patients (NEJM)
  • Convalescent serum for outpatients (medRxiv)
  • Letters read on TWiV 845
  • Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkee

Send your questions for Dr. Griffin to daniel@microbe.tv


fyyd: Podcast Search Engine
share








 December 25, 2021  47m